Characteristic | Group GC (n = 33) | Group NB (n = 33) | P |
---|---|---|---|
Age, mean (SD), y | 63.9 (8.6) | 65.3 (10) | 0.538 |
BMI, mean (SD) | 23.8 (3.3) | 22.5 (3.3) | 0.117 |
Sex | 0.071 | ||
Male | 18 | 25 | |
Female | 15 | 8 | |
Baseline MAP, mean (SD), mmHg | 113.6 (10.6) | 111.3 (12.1) | 0.429 |
Baseline HR, mean (SD), bpm | 71.2 (9.9) | 72.2 (7.9) | 0.652 |
Baseline VAS, mean (SD) | 0.24 (0.7) | 0.12 (0.3) | 0.351 |
Time, mean (SD), min | |||
Surgical | 387.4 (87.5) | 355.6 (74.4) | 0.116 |
Post-anesthesia recovery* | 64.2 (37) | 51.7 (27) | 0.119 |
Sufentanil, mean (SD), µg | 63.2 (10) | 61.9 (11.4) | 0.636 |
Remifentanil, mean (SD), mg | 2.4 (0.8) | 2 (0.6) | 0.066 |
Output | |||
Urine, median (IQR), mL | 600 (500–800) | 600(300–700) | 0.219 |
Blood, median (IQR), mL | 200 (100–275) | 200 (100–250) | 0.963 |
Infusion | |||
Solution, median (IQR), mL | 2500 (2050–3000) | 2500 (2000–3000) | 0.32 |
RBC, mean (SD), mL | 92.4 (239.2) | 111.2 (240.9) | 0.752 |